Medical technology company GE HealthCare (NASDAQ: GEHC) announced on Wednesday that it has introduced a new AI-enabled application orchestration feature, integrated into its True PACS and Centricity PACS systems, through a collaboration with Blackford.
This new offering aims to assist radiologists in managing increased workloads and exam complexities, enabling quicker diagnoses and treatments. The platform provides access to a catalog of third-party AI applications, covering areas from mammography to lung scans.
As clinician burnout rises - 49% of radiologists cited excessive bureaucratic tasks as a key issue in an RSNA survey - GE HealthCare's AI solutions focus on improving workflow efficiency. This aligns with the company's precision care framework, which integrates smart devices, targeted therapies, and digital solutions to enhance care quality.
GE HealthCare currently leads the U.S. Food and Drug Administration's (FDA) list of AI-enabled medical devices, with 80 clearances to date. The AI orchestration feature simplifies the integration of AI into clinical workflows, offering a streamlined process for healthcare providers to access and implement imaging AI solutions.
The new technology will be showcased at the Radiological Society of North America's annual meeting in Chicago from 1-4 December 2023.
Akura Medical's application for trial of Katana Thrombectomy System receives US FDA approval
Amphix Bio receives USD1m SBIR Phase II grant from National Science Foundation
PharmaNutra signs agreement with strategic consulting firm for US development plan
BD launches advanced Intraosseous Vascular Access System for rapid emergency use
Pulsenmore to supply 25,000 home ultrasound devices to Clalit Health Services
Medtronic announces new, long-term data from SPYRAL HTN-ON MED clinical trial
Senzime unveils next-gen TetraGraph TOF monitor at ANESTHESIOLOGY 2024; US shipments to begin in Q4
Abbott launches new clinical trial to improve results in patients with advanced heart failure
United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service
Adocia patents stable hormone combinations for obesity and diabetes